Skip to main content
JINZI HAM CO.,LTD. logo

JINZI HAM CO.,LTD. — Investor Relations & Filings

Ticker · 002515 ISIN · CNE100000XR1 LEI · 300300VVE97TSPV9T045 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,983 across all filing types
Latest filing 2018-04-18 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002515

About JINZI HAM CO.,LTD.

https://www.jinzichina.com

JINZI HAM CO.,LTD. specializes in the production, processing, and distribution of traditional dry-cured meat products, with a primary focus on Jinhua ham. The company utilizes traditional fermentation and curing techniques combined with modern food processing technology to produce a diverse range of products, including hams, sausages, bacon, and sauce-marinated meats. In addition to its core meat business, the company has expanded into the development of plant-based protein products, leveraging research and development to meet evolving consumer preferences. Its operations emphasize quality control and food safety throughout the supply chain, catering to both domestic and international markets. The company's product portfolio is characterized by its adherence to geographical indication standards for Jinhua ham, ensuring authentic flavor profiles and high nutritional value.

Recent filings

Filing Released Lang Actions
关于提供信息和文件真实、准确、完整的承诺函
Regulatory Filings Classification · 95% confidence The document consists of multiple commitment letters from various investment partners regarding the provision of true, accurate, and complete information and documents related to a major asset restructuring transaction involving the acquisition of 81.23% equity in Jiangsu Chenpai Pharmaceutical Group Co., Ltd. by Jinzi Ham Co., Ltd. The document is a legal commitment or undertaking related to a transaction, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis. It is not a report publication announcement since it contains substantive content (commitment letters). The document is best classified as a Regulatory Filing (RNS) because it is a legal/regulatory document related to compliance and disclosure obligations in a transaction context, but does not fit into more specific categories like M&A filings or capital updates, as it is a commitment letter rather than the transaction announcement itself.
2018-04-18 Chinese
第四届董事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 14th meeting of the 4th Board of Directors of 金字火腿股份有限公司 (Jin Zi Ham Co., Ltd.). It discusses approval of a major asset restructuring involving the purchase of 81.23% shares of 江苏晨牌药业集团股份有限公司 (Jiangsu Chenpai Pharmaceutical Group Co., Ltd.), including details on the transaction structure, pricing, related party transactions, performance commitments, legal compliance, and authorization for further actions. The document references relevant laws and regulations governing major asset restructurings and repeatedly states that the matters will be submitted to the shareholders' meeting for approval. The content is focused on board-level decisions and approvals related to a significant corporate transaction, not the transaction itself or a full financial report. It is not a full Annual Report, Interim Report, or Earnings Release. It is not a proxy statement or voting results announcement. It is not a regulatory filing or legal proceeding update. The document is a Board/Management Information announcement about board resolutions on a major asset restructuring and related corporate governance matters. Therefore, the appropriate classification is MANG (Board/Management Information). The document length (9310 characters) and detailed content support this classification with high confidence.
2018-04-18 Chinese
第四届监事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed by the Supervisory Board of Jinzi Ham Co., Ltd. regarding a major asset restructuring involving the acquisition of 81.23% shares of Jiangsu Chenpai Pharmaceutical Group Co., Ltd. It includes voting results, legal and regulatory references, transaction details, pricing, compensation arrangements, and compliance with relevant laws and regulations. The document is not a full financial report but a formal announcement of board resolutions related to a significant corporate transaction. It is not a proxy statement, merger proxy, or a full merger filing but rather a supervisory board meeting resolution announcement. Given the content focuses on management/board decisions and approvals, the best fitting category is Board/Management Information (MANG). The document length (7255 characters) and detailed content support this classification rather than a brief announcement or a full report.
2018-04-18 Chinese
中小板上市公司重大资产重组方案首次披露对照表
M&A Activity Classification · 95% confidence The document is a detailed disclosure related to a major asset restructuring plan of a listed company, including extensive compliance checklists, regulatory references, financial advisor opinions, legal opinions, and various approvals. It discusses the purchase and sale of assets, compliance with regulatory requirements, and detailed financial and legal documentation related to the restructuring. The content aligns with filings related to merger, acquisition, or major asset restructuring activities. Given the focus on a major asset restructuring plan and related regulatory compliance, the document fits best under the category of M&A Activity (TAR). The document length and detail confirm it is the actual filing, not just an announcement or summary.
2018-04-18 Chinese
上海市锦天城律师事务所关于公司重大资产购买暨关联交易相关人员买卖股票情况的法律意见书
Audit Report / Information Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the stock trading activities of related parties in connection with a major asset purchase and related party transaction by Jinzi Ham Co., Ltd. It details the investigation and legal assessment of insider trading allegations during a specific period around the transaction. The document includes detailed stock transaction tables and legal conclusions about the absence of insider trading. It is not a financial report, earnings release, or management discussion, nor is it an announcement of voting results or a proxy statement. It is a standalone legal opinion related to audit and compliance matters concerning the transaction and insider trading. Therefore, it fits best under the category of Audit Report / Information (AR), which includes applied accounting principles and results of internal or regulatory stress tests or legal compliance reports related to transactions, excluding full annual reports. FY 2018
2018-04-18 Chinese
关于重大资产重组暂不复牌的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from Jinzi Ham Co., Ltd. regarding the suspension of trading due to a major asset restructuring. It references regulatory requirements from the China Securities Regulatory Commission and Shenzhen Stock Exchange, mentions ongoing disclosure obligations, and states that the stock will remain suspended pending review and approval of the restructuring plan. The document does not contain financial statements or detailed financial data but is an update on the status of a capital restructuring process and trading suspension. It is not a full report, audit, or financial statement but an official announcement related to capital/financing activities and stock suspension. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is short (1024 characters), but it is not merely a report publication announcement; it provides substantive update information on the capital restructuring and trading suspension status.
2018-04-18 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.